The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Nuclear factor-κB in cancer development and progression
Abstract
Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When NF-κB is activated, transcription of proinflammatory immune response genes such as Tnfα and Il1 occurs, which leads to translation and production of proinflammatory cytokines that serve to coordinate the inflammatory response (Karin, 2006).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Karin, 2006
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,010
Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage
Kilareski, E. M., Shah, S., Nonnemacher, M. R., & Wigdahl, B. L. (2009) · Retrovirology · doi:10.1186/1742-4690-6-118 · Cited by 116
Control of B Lymphocyte Apoptosis by the Transcription Factor NF-κB
Sen, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.12.003 · Cited by 106
Ando, M., Uehara, I., Kogure, K., Asano, Y., Nakajima, W., Abe, Y., Kawauchi, K., & Tanaka, N. (2010) · Journal of Nippon Medical School · doi:10.1272/jnms.77.97 · Cited by 107
Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis
Palma, M. D., & Naldini, L. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.003 · Cited by 106
Leeman‐Neill, R. J., Cai, Q., Joyce, S. C., Thomas, S. M., Bhola, N. E., Neill, D. B., Arbiser, J. L., & Grandis, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0333 · Cited by 106
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype.
Sorrentino, C., & Carlo, E. D. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0400oc · Cited by 100
Roles for Inflammation and Regulatory T Cells in Colon Cancer
Erdman, S. E., & Poutahidis, T. (2009) · Toxicologic Pathology · doi:10.1177/0192623309354110 · Cited by 105
Singh, R. K., & Lokeshwar, B. L. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-57 · Cited by 105
Autophagy and NF-κB: Fight for fate
Xiao, G. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.04.006 · Cited by 107
Pal, S., Kozono, D., Yang, X., Fendler, W., Fitts, W., Ni, J., Alberta, J. A., Zhao, J., Liu, K. X., Bian, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3691 · Cited by 101
Gupta, S. C., Prasad, S., Rajalekshmi, D. S., Nair, M. S., Mo, Y.-Y., & Aggarwal, B. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0080 · Cited by 104
Unraveling the clonal hierarchy of somatic genomic aberrations
Prandi, D., Baca, S. C., Romanel, A., Barbieri, C. E., Mosquera, J., Fontugne, J., Beltran, H., Sboner, A., Garraway, L. A., Rubin, M. A., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0439-6 · Cited by 102
Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance
Hopewell, E. L., Zhao, W., Fulp, W. J., Bronk, C. C., Lopez, A. S., Massengill, M. T., Antonia, S. J., Celis, E., Haura, E. B., Enkemann, S. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67250 · Cited by 105
Shirai, Y., Shiba, H., Sakamoto, T., Horiuchi, T., Haruki, K., Fujiwara, Y., Futagawa, Y., Ohashi, T., & Yanaga, K. K. (2015) · Surgery · doi:10.1016/j.surg.2015.03.043 · Cited by 103
Yin-Yang Activities and Vicious Cycles in the Tumor Microenvironment
Witz, I. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2917 · Cited by 102
Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells
Li, J., Wang, K., Chen, X., Meng, H., Song, M., Wang, Y., Xu, X., & Bai, Y. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-4 · Cited by 105
Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell Carcinoma
Rao, S. K., Pavicevic, Z., Du, Z., Kim, J.-G., Fan, M., Jiao, Y., Rosebush, M. S., Samant, S., Gu, W., Pfeffer, L. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150490 · Cited by 102
Locatelli, M., Ferrero, S., Boneschi, F. M., Boiocchi, L., Zavanone, M. L., Gaini, S. M., Bello, L., Valentino, S., Barbati, E., Nebuloni, M., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.009 · Cited by 101
NF-κB and Its Role in Checkpoint Control
Betzler, A. C., Theodoraki, M., Schuler, P. J., Döscher, J., Laban, S. A., Hoffmann, T. K., & Brunner, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113949 · Cited by 106
Type I Interferons as Anti-Inflammatory Mediators
Benveniste, E. N., & Qin, H. (2007) · Science s STKE · doi:10.1126/stke.4162007pe70 · Cited by 107
A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers
Gu, Y., Tang, S., Wang, Z., Cai, L., Lian, H., Shen, Y., & Zhou, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1973220 · Cited by 99
MicroRNA-mediated breast cancer metastasis: from primary site to distant organs
Wang, L., & Wang, J. (2011) · Oncogene · doi:10.1038/onc.2011.444 · Cited by 102
miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops
Song, L., Lin, C., Gong, H., Wang, C., Liu, L., Wu, J., Tao, S., Hu, B., Cheng, S., Li, M., et al. (2012) · Cell Research · doi:10.1038/cr.2012.174 · Cited by 102
Shukla, S., Shankar, E., Fu, P., MacLennan, G. T., & Gupta, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138710 · Cited by 101
Li, W., Guo, Y., Zhang, C., Wu, R., Yang, Y., Gaspar, J. M., & Kong, A. T. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00413 · Cited by 101
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
Ng, S. W., Chan, Y., Chellappan, D. K., Madheswaran, T., Zeeshan, F., Chan, Y. L., Collet, T., Gupta, G., Oliver, B. G. G., Wark, P. A. B., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.051 · Cited by 101
Doody, K. M., Bourdeau, A., & Tremblay, M. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00743.x · Cited by 101
Human Leukocyte Antigen–G and Cancer Immunoediting
Urosevic, M., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2704 · Cited by 101
Hamsa, T. P., & Kuttan, G. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.589437 · Cited by 100
Jin, R., Yamashita, H., Yu, X., Wang, J., Franco, O. E., Wang, Y., Hayward, S. W., & Matusik, R. J. (2014) · Oncogene · doi:10.1038/onc.2014.302 · Cited by 104
Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice
Vlantis, K., Wullaert, A., Sasaki, Y., Schmidt‐Supprian, M., Rajewsky, K., Roskams, T., & Pasparakis, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45349 · Cited by 101
The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy
Gammeren, D. V., Damrauer, J. S., Jackman, R. W., & Kandarian, S. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-114249 · Cited by 102
Chang, H., Wang, Y., Yin, X., Liu, X., & Xuan, H. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1984-9 · Cited by 104
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Huelse, J. M., Fridlyand, D. M., Earp, S. H., DeRyckere, D., & Graham, D. K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107577 · Cited by 101
Liang, Z., Liu, H., Xiong, L., Yang, X., Wang, F., Zeng, Z., He, X., Wu, X., & Lan, P. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01404-9 · Cited by 101
NF-κB signaling in cancer stem cells: a promising therapeutic target?
Vázquez-Santillán, K., Meléndez-Zajgla, J., Jiménez-Hernández, L., Martinez‐Ruíz, G. U., & Maldonado, V. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0236-6 · Cited by 103
Mabb, A. M., & Miyamoto, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7005-2 · Cited by 101
Yang, F., Li, J., Zhu, J., Wang, D., Chen, S., & Bai, X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.015 · Cited by 99
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
Li, C., Chen, S., Yue, P., Deng, X., Lonial, S., Khuri, F. R., & Sun, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072694 · Cited by 99
NF-κB in pancreatic cancer: Its key role in chemoresistance
Li, Q., Yang, G., Feng, M., Zheng, S., Cao, Z., Qiu, J., You, L., Zheng, L., Hu, Y., Zhang, T., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.011 · Cited by 100
Evidence of Flavonoids on Disease Prevention
Li, M., Qian, M., Jiang, Q., Tan, B., Yin, Y., & Han, X. (2023) · Antioxidants · doi:10.3390/antiox12020527 · Cited by 103
Signalling at tight junctions during epithelial differentiation and microbial pathogenesis
Zihni, C., Balda, M. S., & Matter, K. (2014) · Journal of Cell Science · doi:10.1242/jcs.145029 · Cited by 102
Naturally Occurring Hydroxytyrosol: Synthesis and Anticancer Potential
Bernini, R., Merendino, N., Romani, A., & Velotti, F. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804999367 · Cited by 100
Gastonguay, A. J., Berg, T. J., Hauser, A. D., Schuld, N. J., Lorimer, E., & Williams, C. L. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20082 · Cited by 101
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
Yang, J., Splittgerber, R. C., Yull, F. E., Kantrow, S. M., Ayers, G. D., Karin, M., & Richmond, A. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42358 · Cited by 102
Self-citationNF-κB as a target for cancer therapy
Melisi, D., & Chiao, P. J. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.133 · Cited by 99
Júnior, R. G. D. O., Adrielly, A. F. C., Almeida, J. R. G. D. S., Grougnet, R., Thiéry, V., & Picot, L. (2018) · Fitoterapia · doi:10.1016/j.fitote.2018.02.025 · Cited by 96
Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression
Ivanov, V. N., Partridge, M. A., Johnson, G. E., Huang, S. X. L., Zhou, H., & Hei, T. K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.012 · Cited by 100
Chapter 5 Expression of Chemokines and Chemokine Receptors in Human Colon Cancer
Erreni, M., Bianchi, P. P., Laghi, L., Mirolo, M., Fabbri, M., Locati, M., Mantovani, A., & Allavena, P. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05205-7 · Cited by 98
Schauer, I. G., Zhang, J., Xing, Z., Guo, X. Q., Mercado‐Uribe, I., Sood, A. K., Huang, P., & Liu, J. (2013) · Neoplasia · doi:10.1593/neo.121228 · Cited by 102
Zheng, M., Morgan-Lappe, S. E., Yang, J., Bockbrader, K., Pamarthy, D., Thomas, D. G., Fesik, S. W., & Sun, Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0632 · Cited by 98
Singh, R. (2017) · Frontiers in Bioscience-Elite · doi:10.2741/e798 · Cited by 97
Radiation Resistance: A Matter of Transcription Factors
Galeaz, C., Totis, C., & Bisio, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.662840 · Cited by 101
Signalling by the βc family of cytokines
Hercus, T. R., Dhagat, U., Kan, W. L., Broughton, S. E., Nero, T. L., Perugini, M., Sandow, J. J., D’Andrea, R. J., Ekert, P. G., Hughes, T. P., et al. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.002 · Cited by 97
Shimizu, T., Marusawa, H., Endo, Y., & Chiba, T. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02293.x · Cited by 99
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
Bjørn, M. E., & Hasselbalch, H. C. (2015) · Mediators of Inflammation · doi:10.1155/2015/648090 · Cited by 100
Yang, J., Li, B., & He, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0661-3 · Cited by 98
Immunity drives TET1 regulation in cancer through NF-κB
Collignon, É., Canale, A., Wardi, C. A., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W. J., Wilson, A. J., et al. (2018) · Science Advances · doi:10.1126/sciadv.aap7309 · Cited by 96
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Ebrahimi, N., Abdulwahid, A. R. R., Mansouri, A., Karimi, N., Bostani, R. J., Beiranvand, S., Adelian, S., Khorram, R., Vafadar, R., Hamblin, M. R., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05098-8 · Cited by 101
Intrinsic immunomodulatory hydrogels for chronic inflammation
Qian, Y., Ding, J., Zhao, R., Song, Y., Yoo, J., Moon, H., Koo, S., Kim, J. S., & Shen, J. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00450g · Cited by 100
Regulatory feedback loop between NF‐κB and MCP‐1‐induced protein 1 RNase
Skalniak, Ł., Mizgalska, D., Zarebski, A. P., Wyrzykowska, P., Koj, A., & Jura, J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07273.x · Cited by 96
Longoni, N., Sarti, M., Albino, D., Civenni, G., Malek, A. V., Ortelli, E., Pinton, S., Grand, M. M., Ostano, P., D’Ambrosio, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4537 · Cited by 96
Shin, S. Y., Nam, J., Lim, Y., & Lee, Y. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128124 · Cited by 96
Apoptosis‐inducing effect of garcinol is mediated by NF‐κB signaling in breast cancer cells
Ahmad, A., Wang, Z. P., Raza, A., Maitah, M. Y., Kong, D., Banerjee, S., Padhyé, S., & Sarkar, F. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22492 · Cited by 96
Eddy, J. A., Hood, L., Price, N. D., & Geman, D. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000792 · Cited by 95
Gommeaux, J., Cano, C. E., Garcia, S., Gironella, M., Pietri, S., Culcasi, M., Pébusque, M., MALISSEN, B., Dusetti, N., Iovanna, J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01454-06 · Cited by 95
Ma, K., Cao, B., & Guo, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0210-9 · Cited by 96
Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway
Concannon, C. G., Koehler, B. F., Reimertz, C., Murphy, B. M., Bonner, C., Thurow, N., Ward, M. W., Villunger, A., Strasser, A., Kögel, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1209974 · Cited by 95
Ren, X., Chen, C., Luo, Y., Liu, M., Li, Y., Zheng, S., Ye, H., Fu, Z., Li, M., Li, Z., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01153-1 · Cited by 95
Zalfa, C., & Paust, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633205 · Cited by 100
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Sica, A., Porta, C., Morlacchi, S., Banfi, S., Strauss, L., Rimoldi, M., Totaro, M. G., & Riboldi, E. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0091-6 · Cited by 96
Harpaz, N., & Polydorides, A. D. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.6.876 · Cited by 96
TAK1 regulates hepatic cell survival and carcinogenesis
Roh, Y. S., Song, J., & Seki, E. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-013-0931-x · Cited by 95
Strickertsson, J. A. B., Desler, C., Martin-Bertelsen, T., Machado, A. M. D., Wadström, T., Winther, O., Rasmussen, L. J., & Friis-Hansen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063147 · Cited by 99
NF-??B in the pathogenesis and treatment of multiple myeloma
Li, Z., Chen, H., Campbell, R. A., Bonavida, B., & Berenson, J. R. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328302c7f4 · Cited by 97
Ikner, A., & Ashkenazi, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203745 · Cited by 94
Lu, Z., Jin, Y., Chen, C., Li, J., Cao, Q., & Pan, J. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-112 · Cited by 93
Supreme EnLIGHTenment: Damage Recognition and Signaling in the Mammalian UV Response
Herrlich, P. A., Karin, M., & Weiß, C. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.01.001 · Cited by 94
Self-citationThe role and regulation of the nuclear receptor co-activator AIB1 in breast cancer
Lahusen, T. J., Henke, R. T., Kagan, B. L., Wellstein, A., & Riegel, A. T. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0405-2 · Cited by 96
Chen, J., CHEN, A. Y., Huang, H., Ye, X., Rollyson, W. D., Perry, H. E., Brown, K. C., Rojanasakul, Y., Rankin, G. O., Dasgupta, P., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2946 · Cited by 93
Recent advances in the genetics of systemic lupus erythematosus
Thibault, D. L., Sun, X., Behrens, T. W., Graham, R., & Criswell, L. A. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.8 · Cited by 93
de Chambrun, G. P., Blanc, P., & Peyrin‐Biroulet, L. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1174064 · Cited by 93
Gadd45β promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling
Papa, S., Zazzeroni, F., Fu, Y., Bubici, C., Alvarez, K., Dean, K., Christiansen, P. A., Anders, R. A., & Franzoso, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33913 · Cited by 92
Recent Advances in the Research of Hepatitis B Virus-Related Hepatocellular Carcinoma
Kao, J., Chen, P., & Chen, D. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00002-9 · Cited by 93
Takata, A., Otsuka, M., Yoshikawa, T., Kishikawa, T., Hikiba, Y., Obi, S., Goto, T., Kang, Y. J., Maeda, S., Yoshida, H., et al. (2012) · Hepatology · doi:10.1002/hep.26011 · Cited by 92
“In vitro” 3D models of tumor-immune system interaction
Hirt, C., Papadimitropoulos, A., Mele, V., Muraro, M. G., Mengus, C., Iezzi, G., Terracciano, L., Martín, I., & Spagnoli, G. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.003 · Cited by 93
Loss of SPARC in bladder cancer enhances carcinogenesis and progression
Said, N. A., Frierson, H. F., Sänchez‐Carbayo, M., Brekken, R. A., & Theodorescu, D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64782 · Cited by 92
Ji, X., Wang, Z. P., Geamanu, A., Sarkar, F. H., & Gupta, S. V. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23184 · Cited by 92
Xia, J.-T., Chen, L., Jian, W., Wang, K., Yang, Y., He, W., He, Y., Chen, D., & Li, W. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-33 · Cited by 92
The Emerging Role of TRAF7 in Tumor Development
Zotti, T., Scudiero, I., Vito, P., & Stilo, R. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25676 · Cited by 92
Functional role of CCL5/RANTES for HCC progression during chronic liver disease
Mohs, A., Kuttkat, N., Reißing, J., Zimmermann, H. W., Sonntag, R., Proudfoot, A. E. J., Youssef, S. A., de Bruin, A., Cubero, F. J., & Trautwein, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.011 · Cited by 93
Raucci, M. G., Fasolino, I., Caporali, M., Serrano‐Ruiz, M., Soriente, A., Peruzzini, M., & Ambrosio, L. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b21592 · Cited by 92
Reactive oxygen species: an Achilles’ heel of melanoma?
Fruehauf, J. P., & Trapp, V. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.11.1751 · Cited by 92
Regulation of Autophagy by NF-kappaB Transcription Factor and Reactives Oxygen Species
Djavaheri‐Mergny, M., Amelotti, M., Mathieu, J., Besançon, F., Bauvy, C., & Codogno, P. (2007) · Autophagy · doi:10.4161/auto.4248 · Cited by 92
Wang, J., Wang, X., Hussain, S., Zheng, Y., Sanjabi, S., Ouaaz, F., & Beg, A. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6777 · Cited by 92
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 99
Modulation of the immune response by Middle East respiratory syndrome coronavirus
Shokri, S., Mahmoudvand, S., Taherkhani, R., & Farshadpour, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27155 · Cited by 90
Ramphal, W., Boeding, J. R. E., Gobardhan, P. D., Rutten, H. J. T., de Winter, L. J. M. B., Crolla, R. M. P. H., & Schreinemakers, J. M. J. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2018.10.003 · Cited by 91
Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases
Xu, J., Cao, K., Liu, X., Zhao, L., Feng, Z., & Liu, J. (2021) · Antioxidants · doi:10.3390/antiox11010029 · Cited by 97
Jain, R., Hussein, M. A., Pierce, S., Martens, C., Shahagadkar, P., & Munirathinam, G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106138 · Cited by 94
Metadata
- Authors
- Karin, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- ORCID
- Karin, Michael
- Venue
- Nature
- Published
- 2006-05
- Volume
- 441
- Issue
- 7092
- Pages
- 431-436
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2315613727
- Cited by
- 3,519
- References
- 71
- Citations by year
- 2026: 60 · 2025: 97 · 2024: 111 · 2023: 118 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 133 · 2018: 168 · 2017: 149 · 2016: 192 · 2015: 235 · 2014: 203 · 2013: 231 · 2012: 250
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- NF-κB, carcinogenesis, tumor progression, inflammation and cancer, apoptosis resistance, tumor surveillance, tumor angiogenesis, tumour invasiveness, chemoprevention, chemotherapeutic target, NF-κB signaling
- MeSH terms
- Animals, Humans, Inflammation, Liver Neoplasms, Neoplasms, Skin Neoplasms, NF-kappa B, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review